We found that DBZ is a putative PPARγ partial activator capable of preventing insulin resistance, obesity, and atherosclerosis in mice without significant unwanted effects [51,52]. The gene discussed is ZNF365; the disease is obesity due to melanocortin 4 receptor deficiency.